Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10647703 Inhibitors of KRAS G12C mutant proteins

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

May 12, 2020

Patent Application Number

15763798

Date Filed

September 27, 2016

Patent Citations

US Patent 10370386 Substituted quinolines as inhibitors of KRAS G12C

US Patent 10351550 Substituted quinazoline compounds and methods of use thereof

US Patent 10377743 Inhibitors of RAS and methods of use thereof

US Patent 10111874 Combination therapies for treatment of cancer

US Patent 10144724 Substituted quinazoline compounds and methods of use thereof

Patent Citations Received

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

0

US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof

US Patent 11377441 Covalent inhibitors of KRAS

US Patent 11878985 Substituted quinazolines as inhibitors of KRAS G12C

0

US Patent 10829458 Substituted quinazoline compounds and methods of use thereof

US Patent 10858343 Inhibitors of KRAS G12C mutant proteins

US Patent 10919850 Covalent inhibitors of KRas G12C

US Patent 10927125 Substituted cinnolines as inhibitors of KRAS G12C

...

Patent Primary Examiner

Laura L. Stockton

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10647703 Inhibitors of KRAS G12C mutant proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool